» Articles » PMID: 8666388

A Novel PCR Technique Using Alu-specific Primers to Identify Unknown Flanking Sequences from the Human Genome

Overview
Journal Genomics
Specialty Genetics
Date 1995 Sep 20
PMID 8666388
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The rapid and reproducible identification of new cellular DNA sequences adjacent to known sequences is difficult to achieve with the currently available procedures. Here we describe a novel approach based on the polymerase chain reaction (PCR) using a primer specific to the known sequence and another directed to a human Alu repeat. To avoid undesirable amplifications between Alu sequences, primers are constructed with dUTPs and destroyed by uracil DNA glycosylase treatment after 10 initial cycles of amplification. Only desirable fragments are then further amplified with specific primers to the known region and to a tag sequence introduced in the Alu-specific primer. Using this protocol, we have successfully identified cellular sequences flanking integrated hepatitis B virus DNA from the human genome of three hepatoma tissues. The method enables a direct specific amplification without any ligation or nonspecific annealing steps as required by previous PCR-based protocols. This rapid and straightforward approach will be a powerful tool for the study of viral integration sites, but is also widely applicable to other studies of the human genome.

Citing Articles

Integrated DNA estimation in tissue biopsy and detection in liquid biopsy by HBV-targeted NGS assay.

Liu H, Lin S, Ramirez R, Chen S, Heimer Z, Kubas R medRxiv. 2024; .

PMID: 39677449 PMC: 11643158. DOI: 10.1101/2024.12.04.24318256.


Two fragments of HBV DNA integrated into chrX: 11009033 and its genetic regulation in HepG2.2.15.

Ruan P, Zhou R, He C, Huang C, Lin M, Yin H Mol Med Rep. 2023; 27(5).

PMID: 36960866 PMC: 10086561. DOI: 10.3892/mmr.2023.12985.


DNA methylation at hepatitis B virus integrants and flanking host mitochondrially encoded cytochrome C oxidase III.

Oikawa R, Watanabe Y, Yotsuyanagi H, Yamamoto H, Itoh F Oncol Lett. 2022; 24(6):424.

PMID: 36284651 PMC: 9580253. DOI: 10.3892/ol.2022.13544.


Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure.

Salpini R, DAnna S, Benedetti L, Piermatteo L, Gill U, Svicher V Front Microbiol. 2022; 13:972687.

PMID: 36118192 PMC: 9478028. DOI: 10.3389/fmicb.2022.972687.


Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery.

Zhao K, Liu A, Xia Y Innovation (Camb). 2021; 1(2):100034.

PMID: 34557710 PMC: 8454683. DOI: 10.1016/j.xinn.2020.100034.